Condensed Consolidated and Combined Statements of Equity (Unaudited) - USD ($)
|
Total |
Common Shares Outstanding |
Additional Paid-in Capital |
Retained Earnings |
Accumulated Other Comprehensive Income |
Treasury Stock, Common |
Retained Earnings, Appropriated [Member] |
| Balance as of beginning of period, shares at Dec. 31, 2024 |
|
78,000,000
|
|
|
|
|
|
| Balance as of beginning of period, value at Dec. 31, 2024 |
$ 650,000,000
|
$ 1,000,000
|
$ 1,647,000,000
|
$ 654,000,000
|
$ 17,000,000
|
$ (1,669,000,000)
|
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
| Net income |
61,000,000
|
|
|
61,000,000
|
|
|
|
| Period change |
(13,000,000)
|
|
|
|
(13,000,000)
|
|
|
| Dividends |
$ (32,000,000)
|
|
|
(32,000,000)
|
|
|
|
| Repurchase of common stock (in shares) |
(1,000,000)
|
|
|
|
|
|
|
| Repurchase of common stock |
$ (76,000,000)
|
|
|
|
|
(76,000,000)
|
|
| Net share settlement of incentive equity awards |
(22,000,000)
|
|
(22,000,000)
|
|
|
|
|
| Change in deferred compensation |
$ 10,000,000
|
|
10,000,000
|
|
|
|
|
| Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures |
1,000,000
|
|
|
|
|
|
|
| Other |
$ 1,000,000
|
|
(1,000,000)
|
|
|
|
|
| Ending balance, shares at Mar. 31, 2025 |
|
78,000,000
|
|
|
|
|
|
| Balance as of end of period, value at Mar. 31, 2025 |
579,000,000
|
$ 1,000,000
|
1,636,000,000
|
683,000,000
|
4,000,000
|
(1,745,000,000)
|
|
| Balance as of beginning of period, shares at Dec. 31, 2024 |
|
78,000,000
|
|
|
|
|
|
| Balance as of beginning of period, value at Dec. 31, 2024 |
650,000,000
|
$ 1,000,000
|
1,647,000,000
|
654,000,000
|
17,000,000
|
(1,669,000,000)
|
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
| Net income |
253,000,000
|
|
|
|
|
|
|
| Period change |
(16,000,000)
|
|
|
|
|
|
|
| Ending balance, shares at Sep. 30, 2025 |
|
76,000,000
|
|
|
|
|
|
| Balance as of end of period, value at Sep. 30, 2025 |
583,000,000
|
$ 1,000,000
|
1,662,000,000
|
811,000,000
|
1,000,000
|
(1,892,000,000)
|
|
| Balance as of beginning of period, shares at Mar. 31, 2025 |
|
78,000,000
|
|
|
|
|
|
| Balance as of beginning of period, value at Mar. 31, 2025 |
579,000,000
|
$ 1,000,000
|
1,636,000,000
|
683,000,000
|
4,000,000
|
(1,745,000,000)
|
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
| Net income |
87,000,000
|
|
|
87,000,000
|
|
|
|
| Period change |
(2,000,000)
|
|
|
|
(2,000,000)
|
|
|
| Dividends |
$ (32,000,000)
|
|
|
(32,000,000)
|
|
|
|
| Repurchase of common stock (in shares) |
(1,000,000)
|
|
|
|
|
|
|
| Repurchase of common stock |
$ (77,000,000)
|
|
|
|
|
(77,000,000)
|
|
| Change in deferred compensation |
9,000,000
|
|
9,000,000
|
|
|
|
|
| Other |
1,000,000
|
|
(1,000,000)
|
|
|
|
|
| Ending balance, shares at Jun. 30, 2025 |
|
77,000,000
|
|
|
|
|
|
| Balance as of end of period, value at Jun. 30, 2025 |
570,000,000
|
$ 1,000,000
|
1,651,000,000
|
738,000,000
|
2,000,000
|
(1,822,000,000)
|
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
| Exercise of stock options |
5,000,000
|
|
5,000,000
|
|
|
|
|
| Net income |
105,000,000
|
|
|
105,000,000
|
|
|
|
| Period change |
(1,000,000)
|
|
|
|
(1,000,000)
|
|
|
| Dividends |
$ (32,000,000)
|
|
|
(32,000,000)
|
|
|
|
| Repurchase of common stock (in shares) |
(1,000,000)
|
|
|
|
|
|
|
| Repurchase of common stock |
$ (70,000,000)
|
|
|
|
|
(70,000,000)
|
|
| Net share settlement of incentive equity awards |
(1,000,000)
|
|
(1,000,000)
|
|
|
|
|
| Change in deferred compensation |
9,000,000
|
|
9,000,000
|
|
|
|
|
| Ending balance, shares at Sep. 30, 2025 |
|
76,000,000
|
|
|
|
|
|
| Balance as of end of period, value at Sep. 30, 2025 |
583,000,000
|
$ 1,000,000
|
1,662,000,000
|
811,000,000
|
1,000,000
|
(1,892,000,000)
|
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
| Exercise of stock options |
3,000,000
|
|
3,000,000
|
|
|
|
|
| Balance as of beginning of period, shares at Dec. 31, 2025 |
|
75,000,000
|
|
|
|
|
|
| Balance as of beginning of period, value at Dec. 31, 2025 |
468,000,000
|
$ 1,000,000
|
14,000,000
|
471,000,000
|
3,000,000
|
(21,000,000)
|
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
| Net income |
61,000,000
|
|
|
61,000,000
|
|
|
|
| Period change |
5,000,000
|
|
|
|
5,000,000
|
|
|
| Dividends |
$ (33,000,000)
|
|
|
(33,000,000)
|
|
|
|
| Repurchase of common stock (in shares) |
(1,000,000)
|
|
|
|
|
|
|
| Repurchase of common stock |
$ (51,000,000)
|
|
|
|
|
(51,000,000)
|
|
| Net share settlement of incentive equity awards |
(17,000,000)
|
|
(17,000,000)
|
|
|
|
|
| Change in deferred compensation |
$ 10,000,000
|
|
10,000,000
|
|
|
|
|
| Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures |
1,000,000
|
|
|
|
|
|
|
| Other |
$ (1,000,000)
|
|
|
1,000,000
|
|
|
|
| Ending balance, shares at Mar. 31, 2026 |
|
75,000,000
|
|
|
|
|
|
| Balance as of end of period, value at Mar. 31, 2026 |
447,000,000
|
$ 1,000,000
|
12,000,000
|
498,000,000
|
8,000,000
|
(72,000,000)
|
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
| Exercise of stock options |
5,000,000
|
|
5,000,000
|
|
|
|
|
| Balance as of beginning of period, shares at Dec. 31, 2025 |
|
75,000,000
|
|
|
|
|
|
| Balance as of beginning of period, value at Dec. 31, 2025 |
468,000,000
|
$ 1,000,000
|
14,000,000
|
471,000,000
|
3,000,000
|
(21,000,000)
|
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
| Net income |
262,000,000
|
|
|
|
|
|
|
| Period change |
20,000,000
|
|
|
|
|
|
|
| Ending balance, shares at Sep. 30, 2026 |
|
73,000,000
|
|
|
|
|
|
| Balance as of end of period, value at Sep. 30, 2026 |
475,000,000
|
$ 1,000,000
|
33,000,000
|
635,000,000
|
23,000,000
|
(217,000,000)
|
|
| Balance as of beginning of period, shares at Mar. 31, 2026 |
|
75,000,000
|
|
|
|
|
|
| Balance as of beginning of period, value at Mar. 31, 2026 |
447,000,000
|
$ 1,000,000
|
12,000,000
|
498,000,000
|
8,000,000
|
(72,000,000)
|
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
| Net income |
102,000,000
|
|
|
|
|
|
|
| Period change |
6,000,000
|
|
|
|
6,000,000
|
|
|
| Dividends |
$ (33,000,000)
|
|
|
(33,000,000)
|
|
|
|
| Repurchase of common stock (in shares) |
0
|
|
|
|
|
|
|
| Repurchase of common stock |
$ (54,000,000)
|
|
|
|
|
(54,000,000)
|
|
| Change in deferred compensation |
9,000,000
|
|
9,000,000
|
|
|
|
|
| Other |
1,000,000
|
|
0
|
1,000,000
|
|
|
|
| Ending balance, shares at Jun. 30, 2026 |
|
75,000,000
|
|
|
|
|
|
| Balance as of end of period, value at Jun. 30, 2026 |
480,000,000
|
$ 1,000,000
|
23,000,000
|
568,000,000
|
14,000,000
|
(126,000,000)
|
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
| Exercise of stock options |
2,000,000
|
|
2,000,000
|
|
|
|
|
| Net income |
99,000,000
|
|
|
99,000,000
|
|
|
|
| Period change |
9,000,000
|
|
|
|
9,000,000
|
|
|
| Dividends |
$ (32,000,000)
|
|
|
(32,000,000)
|
|
|
|
| Repurchase of common stock (in shares) |
(1,000,000)
|
|
|
|
|
|
|
| Repurchase of common stock |
$ (91,000,000)
|
|
|
|
|
(91,000,000)
|
|
| Change in deferred compensation |
$ 9,000,000
|
|
9,000,000
|
|
|
|
|
| Stockholders' Equity, Other Shares |
(1,000,000)
|
|
|
|
|
|
|
| Other |
$ 0
|
|
|
|
|
|
$ 0
|
| Ending balance, shares at Sep. 30, 2026 |
|
73,000,000
|
|
|
|
|
|
| Balance as of end of period, value at Sep. 30, 2026 |
$ 475,000,000
|
$ 1,000,000
|
33,000,000
|
$ 635,000,000
|
$ 23,000,000
|
$ (217,000,000)
|
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
| Exercise of stock options |
|
|
$ 1,000,000
|
|
|
|
|